Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by G1945Von Jan 04, 2021 9:37am
212 Views
Post# 32214244

RE:Odd,,,,RVX is not even on a google hit list!

RE:Odd,,,,RVX is not even on a google hit list!Happy New Year narmac. I found a much bigger list. Shows bot RVX & Zenith.



Company Country Status Score  
Universiteit Antwerpen Belgium n/a 895 Preview  
CNRS, The French National Center for Scientific Research France n/a 845 Preview  
Zymo Research USA Private 822 Preview  
Constellation Pharmaceuticals USA Private 802 Preview  
The Gurdon Institute United Kingdom n/a 789 Preview  
FORMA Therapeutics USA Private 788 Preview  
Storm Therapeutics United Kingdom Private 776 Preview  
Friedrich Miescher Institute for Biomedical Research Switzerland Private 759 Preview  
Epizyme USA Listed 755 Preview  
Oryzon Genomics, S.A. Spain Private 739 Preview  
MBL International USA n/a 735 Preview  
Aviva Systems Biology USA n/a 734 Preview  
CellCentric United Kingdom Private 727 Preview  
Resverlogix Corp. Canada Listed 720 Preview  
Domainex United Kingdom Private 718 Preview  
Centre for Genomic Regulation Spain n/a 715 Preview  
Instituto de Investigacin Biomdica (IRB Barcelona) Spain n/a 706 Preview  
Oxford Biodynamics United Kingdom Listed 693 Preview  
REACTION BIOLOGY CORPORATION USA n/a 687 Preview  
MDXHEALTH Belgium Listed 684 Preview  
Inventiva France Private 674 Preview  
Zenith Epigenetics Ltd. Canada Private 664 Preview  
Rodin USA Private 661 Preview  
Pronto Diagnostics Unknown n/a 652 Preview  
Diagenode Belgium Private 640




G1945V
<< Previous
Bullboard Posts
Next >>